Unichem Labs Goa facility gets VAI status from USFDA
Mumbai: Unichem Labs has announced that the US Food and Drug Administration (USFDA) has classified the inspection of Company’s Goa formulation facility situated at Pilerne, Bardez as Voluntary Action indicated (“VAI”).
Medical Dialogues team had earlier reported that the Company had received five observations from the USFDA for the inspection conducted from 8th July 2024 to 15th July 2024.
Read also: Unichem Labs gets 5 USFDA observations for Goa facility
Headquartered in Mumbai, Unichem Laboratories Limited is an international, integrated, specialty pharmaceutical company. The company was founded in 1944 by Padmabhushan Late Mr. Amrut V Mody. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in several markets across the world.
Read also: Sandip Ghume to resign as Unichem Labs Deputy CFO, Key Managerial Personnel
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.